An interventional study of Restorative materials- Filtek Silorane and Restorative materials-Kalore in Tooth Diseases, sponsored by Hacettepe University. Completed. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-17.
Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment
Patients with 4 occlusal lesions in molar teeth will be included. Occlusal cavities will be prepared either by Er,Cr:YSGG laser (LS) or conventional diamond bur (BR). Cavities will be restored with Filtek Silorane (3M-ESPE) (SR) and with Kalore (GC) (KR) according to the manufacturers' instructions. All restorative procedures will be performed by one operator and the restorations will be examined by two evaluators according to the FDI (World Dental Federation) criteria at baseline and at 6-month, 1-, 2-,3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-year. Patients' satisfaction about the preparation methods will be evaluated with a survey. Pearson Chi-Square test will be used for statistical analyze(p=0.05).
Exclusion Criteria:
Device: Restorative materials- Filtek Silorane · Device: Preparation-Er,Cr:YSGG Laser
Device: Restorative materials- Filtek Silorane · Device: Preparation- Diamond Bur
Device: Restorative materials-Kalore · Device: Preparation-Er,Cr:YSGG Laser
Device: Restorative materials-Kalore · Device: Preparation- Diamond Bur
Filtek Silorane
Kalore
Er,Cr:YSGG Laser
Bur
Clinical performance of different low-shrinkage composites and preparations
Evaluations according to FDI criteria
Time frame: 10 years
No study locations are listed for this record.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hacettepe University